HeartSciences Inc.
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-9.1M | $-8.8M | $-6.6M | $-6.4M | $-4.8M |
| Depreciation & Amortization | — | — | — | — | — |
| Depreciation | $27.8K | $37.6K | $27.9K | $26.9K | $26.6K |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $1.3M | $249.9K | $405.0K | $248.3K | $68.4K |
| Net Cash from Operating Activities | $-7.4M | $-7.4M | $-6.1M | $-5.8M | $-3.6M |
| Investing Activities | |||||
| Capital Expenditures | $3.6K | $3.2K | $64.5K | $18.3K | $1.9K |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-44.5K | $-30.2K | $-125.3K | $-18.3K | $-1.9K |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $8.0M | $2.7M | $10.3M | $6.5M | $3.8M |
| Net Change in Cash | $558.7K | $-4.7M | $4.1M | $742.2K | $194.8K |
| Free Cash Flow | $-7.4M | $-7.4M | $-6.1M | $-5.8M | $-3.6M |